TRANSKRIBEERI 🔗
WEBVTT
1
00:00:01.399 --> 00:00:04.879
Welcome everyone, and thank you for joining this rebroadcasted session
2
00:00:04.919 --> 00:00:09.359
with Partnerships with Sites. Our session topic for today building
3
00:00:09.400 --> 00:00:14.599
trust driven partnerships Astrasenica's concierge approach to accelerating site activation
4
00:00:14.759 --> 00:00:19.039
and enrollment. Will share how Astrasenica is reimagining sponsor site
5
00:00:19.079 --> 00:00:23.600
relationships through a trust first, high engagement operating model that
6
00:00:23.719 --> 00:00:29.120
emphasizes flexibility, responsiveness, and co creation. Our site engagement lead
7
00:00:29.160 --> 00:00:32.719
speakers Shannon Edwards and Tina Nim will walk you through
8
00:00:32.719 --> 00:00:36.479
how they are embedded approach to collaboration has enabled faster
9
00:00:36.600 --> 00:00:41.880
site activation, stronger recruitment performance, and improved data delivery. Enjoy
10
00:00:41.920 --> 00:00:42.479
the recording.
11
00:00:44.399 --> 00:00:47.000
So I do have to comment on our pants. Tana
12
00:00:47.039 --> 00:00:48.920
and I walked in here this morning and we're like,
13
00:00:49.479 --> 00:00:52.719
oh my gosh, we're dressed like the logo. We didn't
14
00:00:52.719 --> 00:00:55.880
need to do it, but we're in pink and green pants.
15
00:00:56.159 --> 00:00:58.719
We figured we fit in right now we fit in
16
00:00:59.280 --> 00:01:02.119
and the black pap so it's all good. Okay, So
17
00:01:02.280 --> 00:01:05.280
thank you so much for staying. I know we're between
18
00:01:05.319 --> 00:01:09.640
you and one more talk and the reception. So today
19
00:01:09.680 --> 00:01:14.239
we're going to talk about Astrazenica's approach to building trust
20
00:01:14.640 --> 00:01:21.280
driven partnerships with our sites, so we'll anchor ourselves and
21
00:01:21.359 --> 00:01:24.480
our goals first, and so really, I think it was
22
00:01:24.519 --> 00:01:28.400
said before, most sponsors obviously want to be the sponsor
23
00:01:28.400 --> 00:01:32.239
of choice to their clinical trial sites, and how we're
24
00:01:32.280 --> 00:01:36.200
approaching that is really looking at long term partnerships, so
25
00:01:36.719 --> 00:01:41.280
it's not just for a study, it's for the portfolio overall,
26
00:01:41.560 --> 00:01:47.159
and really engaging the site routinely in our discussions and
27
00:01:47.480 --> 00:01:48.040
our work.
28
00:01:49.319 --> 00:01:51.000
We're also looking.
29
00:01:50.760 --> 00:01:55.079
To really value these sites and that they feel that
30
00:01:55.799 --> 00:02:01.640
throughout every phase of a study, whether that be through activation, recruitment,
31
00:02:02.200 --> 00:02:08.479
close out, it's consistent throughout. We also want to obviously
32
00:02:08.560 --> 00:02:16.240
increase recruitment across asrizonaca's portfolio and accelerate study activation, So
33
00:02:16.840 --> 00:02:19.400
we're going to talk about some of the strategies
Load full transcript
that
34
00:02:19.439 --> 00:02:23.439
we've implemented in order to do that. But I really
35
00:02:23.479 --> 00:02:28.319
think the study management efficiencies piece is where we've seen
36
00:02:28.479 --> 00:02:35.560
some really increase or decrease really in study activation because
37
00:02:35.800 --> 00:02:39.680
we've looked at sites on an individual level and sort
38
00:02:39.719 --> 00:02:41.759
of said, how can we meet you in the middle,
39
00:02:42.159 --> 00:02:46.800
And I think that's really been positive for us. So
40
00:02:47.560 --> 00:02:50.520
we started this presentation out a little differently. I think
41
00:02:50.599 --> 00:02:53.639
because we wanted to share that impact first before we
42
00:02:53.719 --> 00:02:55.560
kind of talk about how we got here.
43
00:02:56.719 --> 00:02:58.560
So when our partner.
44
00:02:58.240 --> 00:03:01.960
And care sites really respond and said, you know, how's
45
00:03:02.000 --> 00:03:06.879
Astrozenica performing for us as a program, they said that
46
00:03:06.919 --> 00:03:10.439
we are on part to other sponsors are better than
47
00:03:10.479 --> 00:03:14.960
other sponsors in terms of the program. Overall. We've also
48
00:03:15.080 --> 00:03:20.680
had the opportunity to collaborate with our sites and build
49
00:03:21.400 --> 00:03:25.400
a committee in order to educate each other, and that
50
00:03:25.479 --> 00:03:30.240
has been, you know, really impactful. I think we've had
51
00:03:30.280 --> 00:03:33.080
seen some good survey results from that and it's really
52
00:03:33.120 --> 00:03:38.439
been well attended. In terms of engagement, we've seen an
53
00:03:38.479 --> 00:03:41.919
average increase in the number of studies at our US
54
00:03:42.360 --> 00:03:47.280
partner and care sites since twenty twenty two and an
55
00:03:47.360 --> 00:03:51.360
overall positive engagement score. You know, one thing I'll mention
56
00:03:51.599 --> 00:03:54.199
here and I should have before is that when we
57
00:03:54.280 --> 00:03:58.680
say partner in care, we use that interchangeably with pick
58
00:03:58.879 --> 00:04:06.080
as a short break aviation. So the success in terms
59
00:04:06.080 --> 00:04:10.479
of studies startup. So working collaboratively with our partner and
60
00:04:10.520 --> 00:04:15.719
care sites, we have seen a decrease in the active
61
00:04:15.759 --> 00:04:19.680
budget negotiation time. And what that looks like, I think
62
00:04:19.879 --> 00:04:25.160
is collaborating with these sites to standardize agreements, it's looking
63
00:04:25.199 --> 00:04:29.800
at rate cards. We also assign a partner in Care
64
00:04:30.319 --> 00:04:34.759
negotiator to each site and so that person's consistent throughout
65
00:04:35.720 --> 00:04:40.399
the process, which I think has been a win for sites.
66
00:04:40.480 --> 00:04:44.480
They know they have somebody to contact, that person knows
67
00:04:44.519 --> 00:04:50.680
how they operate, and that has really been helpful. In
68
00:04:50.800 --> 00:04:56.279
terms of decrease in overall activation cycle times, we've seen
69
00:04:56.319 --> 00:05:02.199
a thirty percent decrease, which has been well earned on
70
00:05:02.399 --> 00:05:06.279
the site level and Astrosenica and we'll talk through a
71
00:05:06.319 --> 00:05:08.800
few of the things that we've done, but we've really
72
00:05:08.879 --> 00:05:12.399
tried to be flexible with sites. We all have SOPs
73
00:05:12.439 --> 00:05:15.759
we need to follow, but I think we've tried to
74
00:05:15.800 --> 00:05:19.879
see where we can meet sites where they are, where
75
00:05:19.920 --> 00:05:23.399
we can approve templates that they use, so that it's
76
00:05:23.519 --> 00:05:28.600
just easier and more streamline for the site. And in
77
00:05:28.680 --> 00:05:33.120
terms of success and studies startup, we've seen, you know,
78
00:05:33.160 --> 00:05:36.519
in sixty five percent of studies that the first US
79
00:05:36.600 --> 00:05:42.000
site activated is at a partner and care site. So
80
00:05:42.319 --> 00:05:47.879
turning to study recruitment, we you know, all of these
81
00:05:47.920 --> 00:05:53.000
sites have made a positive impact at Asenica, and we
82
00:05:53.120 --> 00:05:57.199
continually remind them of that fact during our routine calls.
83
00:05:58.160 --> 00:06:02.879
We've also had success with the first US participant being
84
00:06:02.920 --> 00:06:06.560
screened at partnering care sites and so as a group,
85
00:06:07.439 --> 00:06:11.879
these sites are really delivering, and I think it's because
86
00:06:11.920 --> 00:06:15.720
it has been such a collaborative approach between the sites
87
00:06:16.120 --> 00:06:21.319
and our team at Azroseneca. So you know, looking at
88
00:06:21.319 --> 00:06:24.279
the number of sites that we have, it's less than
89
00:06:24.480 --> 00:06:29.639
half in this program, yet there's seventy percent of recruitment,
90
00:06:29.839 --> 00:06:32.639
So I think that kind of number kind of speaks
91
00:06:32.639 --> 00:06:40.439
for itself. So years ago, and actually probably not that
92
00:06:40.560 --> 00:06:44.839
long ago, we outsourced a lot of our oncology studies
93
00:06:44.959 --> 00:06:49.160
and so that has shifted and we have a lot
94
00:06:49.199 --> 00:06:54.279
of studies in house, and so it necessitated having a
95
00:06:54.439 --> 00:06:58.759
US site and management monitoring group. And you can see
96
00:06:58.800 --> 00:07:02.199
we are full service study delivery model and so we
97
00:07:02.240 --> 00:07:08.079
have contract and budget monitoring, study startup and then we
98
00:07:08.160 --> 00:07:12.600
did add site development a few years ago and that's
99
00:07:12.639 --> 00:07:17.439
where you know our team is and it's across supportfolio.
100
00:07:17.439 --> 00:07:22.079
We're not looking at one study, one therapy area. You
101
00:07:22.079 --> 00:07:24.720
can see them listed on the bottom of the screen here.
102
00:07:24.839 --> 00:07:29.399
It's very broad. Therefore, we're looking at the site holistically
103
00:07:30.199 --> 00:07:34.519
and really understanding their processes. And you know, what's important
104
00:07:34.519 --> 00:07:42.399
to the site and trying to meet those needs. So
105
00:07:42.879 --> 00:07:47.040
the evolution of our partnership programs. So not to get
106
00:07:47.079 --> 00:07:50.160
in the weeds here, but I do think this illustrates
107
00:07:50.800 --> 00:07:56.279
how we have taken the feedback from sites and modified
108
00:07:56.319 --> 00:07:59.519
our approach and so you can see, I mean it's
109
00:07:59.519 --> 00:08:02.800
over us sixty year period that we've been doing this
110
00:08:02.920 --> 00:08:06.680
in different iterations, but it's been really important to us
111
00:08:06.720 --> 00:08:09.680
to adapt to meet the needs of the sites as
112
00:08:09.720 --> 00:08:13.800
well as AstraZeneca. And so you know, we we've really
113
00:08:13.879 --> 00:08:16.519
grown our team. There are a few of them here
114
00:08:16.560 --> 00:08:20.120
which we're just representing the work of the full team.
115
00:08:20.279 --> 00:08:24.600
But I think, you know, just the different stages have
116
00:08:24.759 --> 00:08:27.079
led us to this point and we're going to continue
117
00:08:27.120 --> 00:08:30.920
to grow. This is a process improvement effort, wanting to
118
00:08:30.959 --> 00:08:36.080
see what we can do better. So the levels of
119
00:08:36.240 --> 00:08:41.000
the partnerships that we have that we have the preferred
120
00:08:41.080 --> 00:08:46.000
partner site and then the partner and care site. So
121
00:08:46.279 --> 00:08:50.120
I think this approach to kind of a tiered level
122
00:08:50.240 --> 00:08:54.360
system is we've you know, been able to improve at
123
00:08:54.360 --> 00:08:56.919
every level. We've been able to look at sites that
124
00:08:57.399 --> 00:09:00.799
are high performers and really you know, work closely with
125
00:09:00.919 --> 00:09:04.519
those sites, but then also those kind of emerging sites
126
00:09:04.639 --> 00:09:08.480
that we're able to kind of nurture and grow. So
127
00:09:08.559 --> 00:09:12.799
this provides that opportunity and it is flexible. And so
128
00:09:14.080 --> 00:09:19.080
with the preferred partner sites, that's more of an operational partnership,
129
00:09:19.879 --> 00:09:23.000
really looking at how we can align with the site
130
00:09:24.080 --> 00:09:28.519
and learning their processes, making sure there are staff knows
131
00:09:28.600 --> 00:09:32.879
healthy site operates so we can cut down on redundant questions.
132
00:09:34.039 --> 00:09:39.879
Whereas the partner in care relationship is both scientific and operational.
133
00:09:40.519 --> 00:09:43.200
And so in addition to all the things I've kind
134
00:09:43.200 --> 00:09:47.679
of mentioned from an operational standpoint, we also are in
135
00:09:47.919 --> 00:09:53.120
the you know, wanting to engage the PIS in every
136
00:09:53.200 --> 00:09:57.720
aspect of the portfolios. So we are connecting with them
137
00:09:58.159 --> 00:10:03.279
to get input on study design and that is fairly routine.
138
00:10:03.440 --> 00:10:07.320
Their feedback is uh, you know, taken in and shared
139
00:10:07.360 --> 00:10:11.519
with our global team, and we also engage with them
140
00:10:12.320 --> 00:10:17.279
throughout a study. We are sharing the portfolio nearly on
141
00:10:17.320 --> 00:10:22.840
a quarterly basis. I would say our therapy area strategy
142
00:10:22.960 --> 00:10:26.360
heads were meeting with the PIS. So it's a very
143
00:10:26.720 --> 00:10:34.120
engaged model from all facets of an operations standpoint, And
144
00:10:34.200 --> 00:10:36.039
with that, I think I turned it over to you.
145
00:10:39.679 --> 00:10:44.559
Yes, so Shannon brought us through the metrics from our
146
00:10:44.600 --> 00:10:48.399
PICK program and I will give a high level overview
147
00:10:48.480 --> 00:10:52.600
of the strategies to achieve those metrics and a lot
148
00:10:52.639 --> 00:10:55.600
of it's what was discussed today, So I guess it's
149
00:10:55.679 --> 00:10:59.440
tried and true and we do it too. But first
150
00:10:59.639 --> 00:11:02.320
we're going to talk about building trusts with our US
151
00:11:02.440 --> 00:11:05.919
PICK sites, and central to our program is the site
152
00:11:05.960 --> 00:11:10.120
engagement lead, who is the dedicated point of contact for
153
00:11:10.320 --> 00:11:15.600
each PICK site to ensure consistency, transparency and site advocacy
154
00:11:16.759 --> 00:11:20.200
and going beyond our commitment to partner of the site
155
00:11:20.240 --> 00:11:24.480
to ease their data day operational burden. We do really
156
00:11:24.519 --> 00:11:28.879
strive to approach every site interaction with a collaborative mindset.
157
00:11:29.519 --> 00:11:34.320
We are very receptive to the ideas, proposed changes, feedback
158
00:11:34.399 --> 00:11:36.960
that the site shares with us, and we would love
159
00:11:37.039 --> 00:11:39.759
to action all that, but there are times when we
160
00:11:39.960 --> 00:11:43.480
just can't. And when in those times we are transparent
161
00:11:43.559 --> 00:11:47.960
with the rationale and to be the best site advocate,
162
00:11:48.759 --> 00:11:52.159
our most effective site advocate, we do need to seek
163
00:11:52.279 --> 00:11:57.279
input and feedback Whenever ASY rolls out new tools, new processes.
164
00:11:58.559 --> 00:12:01.600
These PICK sites really are our voice of the customer
165
00:12:02.399 --> 00:12:06.759
really letting us know whether our operational framework will meet
166
00:12:06.799 --> 00:12:11.440
site needs. And lastly, to serve as the side engagement lead,
167
00:12:11.840 --> 00:12:14.840
we do want to be consistent in the way we communicate,
168
00:12:15.240 --> 00:12:19.559
so not only in communicating study information and updates,
but
169
00:12:19.600 --> 00:12:23.279
also being frank when there are delays and changes in
170
00:12:23.320 --> 00:12:29.720
our pipeline. Now that we've established our role as the
171
00:12:29.720 --> 00:12:34.000
sign engagement lead, we will just review some strategies to
172
00:12:34.120 --> 00:12:39.919
ensure successful activation and recruitment of Beginning with activation support,
173
00:12:40.120 --> 00:12:44.480
the side engagement lead really tries to investigate and do
174
00:12:44.600 --> 00:12:49.159
a deep dive into understanding the site's activation process. And
175
00:12:49.240 --> 00:12:53.720
this involves not only knowing the step by step process,
176
00:12:53.720 --> 00:12:58.519
but really understanding how does the institution operate, what are
177
00:12:58.519 --> 00:13:03.120
their challenges, what this works for them, and we're the
178
00:13:03.200 --> 00:13:06.080
lucky ones to be in receipt of this information. But
179
00:13:06.159 --> 00:13:09.000
we also want to make sure the broader AISY teams
180
00:13:09.080 --> 00:13:12.200
are aware of the same information so that there is
181
00:13:12.320 --> 00:13:17.879
not redundant conversations. And to streamline those communications, we have
182
00:13:18.000 --> 00:13:22.759
developed an online repository. All AASY study teams have access
183
00:13:22.799 --> 00:13:27.039
to it so they can access information on site specific
184
00:13:27.120 --> 00:13:32.360
activation details when they need it and once we have
185
00:13:32.440 --> 00:13:35.720
an understanding of the activation process. We do want to
186
00:13:35.759 --> 00:13:39.399
work with the site to see what are the strategies
187
00:13:39.440 --> 00:13:43.679
that will be effective in decreasing activation study times, and
188
00:13:43.720 --> 00:13:46.720
Shannon touched on those when she went through the metrics,
189
00:13:46.840 --> 00:13:51.519
but just wanted to add that again. Whenever we implement efficiencies,
190
00:13:51.639 --> 00:13:56.200
that is documented in our online repository for other study
191
00:13:56.240 --> 00:14:03.399
teams to review, and once those efficiencies are implemented, we
192
00:14:03.440 --> 00:14:06.759
do want to work with the site and set activation goals.
193
00:14:07.519 --> 00:14:10.919
Setting the targets together allows us to measure the impact
194
00:14:11.080 --> 00:14:17.039
and allows us to assess for ongoing improvements, and lastly,
195
00:14:17.240 --> 00:14:23.120
to ensure that we continue to improve. We do want
196
00:14:23.159 --> 00:14:26.600
to seek active feedback and with that we have site
197
00:14:26.600 --> 00:14:30.720
engagement leads. We do hold recurring meetings with our partners
198
00:14:30.720 --> 00:14:33.559
and care sites and it's during those meetings that we
199
00:14:34.000 --> 00:14:38.679
want to continue to receive feedback because unless the site
200
00:14:38.720 --> 00:14:43.679
tells us what's the feedback, there's no way for us
201
00:14:43.720 --> 00:14:47.279
to continue the tailor the activation process to the sites
202
00:14:47.320 --> 00:14:51.679
evolving needs. So that continuous cycle of communication has been
203
00:14:51.720 --> 00:14:57.799
really impactful in delivering faster and more consistent, sturdy startups.
204
00:15:00.559 --> 00:15:05.679
Moving on to recruitment support, and during those meetings that
205
00:15:05.759 --> 00:15:08.639
the SIE engagement lead has with their pick sites. There
206
00:15:08.679 --> 00:15:13.360
are focused discussions on study delivery and this ensures that
207
00:15:13.360 --> 00:15:17.679
the easy studies do remain top of mind and the
208
00:15:17.799 --> 00:15:23.600
side engagement lead directs two core discussions. First, we do
209
00:15:23.720 --> 00:15:29.120
align on the goals again that we set, and second,
210
00:15:29.279 --> 00:15:35.679
we do share realistic recruitment expectations for each study. And
211
00:15:35.759 --> 00:15:40.159
then another core discussion that we have is performance benchmarking,
212
00:15:40.759 --> 00:15:45.679
so we do share data about recruitment for each study
213
00:15:45.840 --> 00:15:50.120
and this allows the site to gauge how their activity
214
00:15:50.320 --> 00:15:54.919
in relation to the other sites on the study and
215
00:15:54.960 --> 00:15:58.960
we hope that with this transparent sharing of information it
216
00:15:59.039 --> 00:16:04.720
helps the site us optimize their resources for study delivery.
217
00:16:05.840 --> 00:16:09.639
But we always do encourage our sites to tell us
218
00:16:09.639 --> 00:16:12.840
what they need from us, because unless they tell us,
219
00:16:12.879 --> 00:16:16.360
we don't know how to help them be successful in
220
00:16:16.399 --> 00:16:20.399
their own engagement or their own recruitment strategies. So just
221
00:16:20.480 --> 00:16:27.320
on this slide are just some site directed opportunities, and
222
00:16:27.440 --> 00:16:30.759
reflecting on our journey over the past couple years, there
223
00:16:30.799 --> 00:16:35.919
are some lessons that stand out. The first is the
224
00:16:36.080 --> 00:16:40.480
value of engaging our pick sites early in goal setting discussions,
225
00:16:41.120 --> 00:16:44.559
and we feel that by actively seeking their input on
226
00:16:44.639 --> 00:16:49.519
what's achievable. We do foster greater transparency and site ownership.
227
00:16:50.080 --> 00:16:52.639
And one of the ways that we've actioned this learning
228
00:16:52.720 --> 00:16:56.559
is that we've created a medear health check assessment and
229
00:16:56.600 --> 00:16:59.919
this is a structured review, so it allows us science
230
00:17:00.000 --> 00:17:03.440
engagement lead and the site to see how we're tracking
231
00:17:03.519 --> 00:17:07.640
towards these goals throughout the year, and it allows us
232
00:17:07.680 --> 00:17:11.720
identify risks early so hopefully that there's time to make
233
00:17:11.759 --> 00:17:15.240
a meaningful impact before the end of the year comes around.
234
00:17:17.839 --> 00:17:22.000
And another key learning is the value of focusing on
235
00:17:22.119 --> 00:17:26.200
each pick site strengths rather than taking that one size
236
00:17:26.200 --> 00:17:29.559
fit all approach. And one of the ways that we've
237
00:17:29.680 --> 00:17:32.319
actioned this is that we've created our own just in
238
00:17:32.400 --> 00:17:36.519
time program and for sites that prefer to operate under
239
00:17:36.599 --> 00:17:40.079
this model, it is an opportunity for them. For those
240
00:17:40.119 --> 00:17:43.279
sites that can get up and running really quickly but
241
00:17:43.519 --> 00:17:47.680
predict lower recruitment to still have the opportunity participate in
242
00:17:47.759 --> 00:17:55.720
AstraZeneca studies. And with that, we want to thank the
243
00:17:55.880 --> 00:17:59.200
conference organizers for letting us present on the Partners and
244
00:17:59.240 --> 00:18:02.319
Care program and for all of you for your attention.
245
00:18:03.279 --> 00:18:17.319
Shannon and I will take questions if anybody has any.
246
00:18:14.400 --> 00:18:18.480
I thank you thank you so much. Hopefully the answer
247
00:18:18.519 --> 00:18:20.200
to this first question is yes. So I can ask
248
00:18:20.240 --> 00:18:23.200
a second one before you. The way you partner with
249
00:18:23.240 --> 00:18:27.119
your sites is there beyond staff resources? Are there other
250
00:18:28.319 --> 00:18:30.799
financial ways in which you partner with the site to
251
00:18:30.839 --> 00:18:35.160
provide them things, whether that is through like resources of
252
00:18:36.440 --> 00:18:39.440
patient navigation or anything else that is different than actual
253
00:18:39.519 --> 00:18:40.279
human bodies.
254
00:18:42.319 --> 00:18:44.799
So in terms of and I think what you're asking is,
255
00:18:45.799 --> 00:18:51.640
do we provide them support for data entry recruitment in
256
00:18:51.720 --> 00:18:55.480
terms of pre screen Yes we do. Now we found
257
00:18:55.480 --> 00:19:00.640
that that sites. I'm not sure what the break down is,
258
00:19:00.640 --> 00:19:03.200
but I'd say it's definitely less than half can actually
259
00:19:03.240 --> 00:19:09.279
accept those services due to, you know, giving third party
260
00:19:09.359 --> 00:19:14.920
vendor access to their EMR. There just have been some challenges,
261
00:19:14.960 --> 00:19:18.759
but that is an opportunity that we have available to
262
00:19:19.039 --> 00:19:20.680
all of our partner and care sites.
263
00:19:20.799 --> 00:19:26.240
Yes, how about more like deeper rooted, like permanent weight
264
00:19:26.359 --> 00:19:30.920
like let's say they're they're struggling with and liking on
265
00:19:31.000 --> 00:19:39.960
any sort of example, I apologize patient recruitment, staffing or
266
00:19:40.000 --> 00:19:43.480
an actual permanent role that is for that site, not
267
00:19:43.759 --> 00:19:46.680
like a service, third party service, anything that deeply embeds
268
00:19:46.720 --> 00:19:51.880
them in their community or CTMs access license or anything
269
00:19:51.920 --> 00:19:53.119
that's more permanent.
270
00:19:54.000 --> 00:19:57.640
Yeah, we've done that in unlimited capacity. I would say
271
00:19:57.680 --> 00:20:02.359
that's a newer effort for us. I would I think
272
00:20:02.400 --> 00:20:05.680
that looking at those case studies of what we've done
273
00:20:05.720 --> 00:20:10.000
to date is important. We're in an assessment period for that,
274
00:20:10.359 --> 00:20:14.079
and so there's a lot of potential here with this program.
275
00:20:14.160 --> 00:20:18.839
And honestly, I haven't It's been rare that I've heard
276
00:20:19.079 --> 00:20:22.200
no at astra Zenica when it comes to our sites
277
00:20:22.640 --> 00:20:26.039
and what they need, and I think that's been, you know,
278
00:20:26.119 --> 00:20:29.079
really well received by the sites. If we have to
279
00:20:29.160 --> 00:20:31.839
say no, we're going to tell you why, and it's
280
00:20:32.400 --> 00:20:37.079
it's something that we're comfortable sharing and presenting and and
281
00:20:37.519 --> 00:20:41.119
hopefully aligning on. But yes, we've done those type of
282
00:20:41.759 --> 00:20:46.039
role sponsorships in a limited capacity. I'd say we probably
283
00:20:46.119 --> 00:20:48.519
have four or five of them, Tina, if I had
284
00:20:48.519 --> 00:20:49.720
to estimate so.
285
00:20:49.759 --> 00:20:54.240
Far, So then I'm going to attempt my second question. Apologies.
286
00:20:54.319 --> 00:20:57.240
So I also work for a pharma and I think
287
00:20:57.319 --> 00:20:59.039
one of the ways we would like to try to
288
00:20:59.079 --> 00:21:01.839
help sites is through things like that. But we face
289
00:21:01.880 --> 00:21:05.079
all these weird rules with a legal perspective of whether
290
00:21:05.200 --> 00:21:08.480
or not you're coercion seeing them with those funds, and
291
00:21:08.640 --> 00:21:11.400
just curious if Azy has had any positive experience of
292
00:21:11.440 --> 00:21:15.559
how to go about doing that without coming across as
293
00:21:15.599 --> 00:21:17.599
coercing them.
294
00:21:18.119 --> 00:21:21.640
So I'll be honest, I at a leadership level, I
295
00:21:21.680 --> 00:21:25.240
am not aware of those conversations to that degree or
296
00:21:25.279 --> 00:21:29.759
to that sentiment, I should say, And so no, I'm
297
00:21:29.799 --> 00:21:33.839
not familiar with with that with you, Tina in anyway. No,
298
00:21:34.920 --> 00:21:37.200
thank you so much for the question. We appreciate the
299
00:21:37.240 --> 00:21:39.720
engagement and I know as our time is ub kate,
300
00:21:41.039 --> 00:21:41.480
thank you.
301
00:21:43.160 --> 00:21:45.359
Thank you again for joining us, and a big thank
302
00:21:45.400 --> 00:21:47.880
you to Shannon Edwards and Tina Niam from Asher Zenega.
303
00:21:48.480 --> 00:21:51.160
To learn more information on the twenty twenty six Partnerships
304
00:21:51.200 --> 00:21:55.440
with Sites event, please visit Partnerships with Sites dot Com.
305
00:21:55.480 --> 00:21:56.039
Thanks again